Raymond James Financial Inc Legend Biotech Corp Transaction History
Raymond James Financial Inc
- $299 Billion
- Q3 2025
A detailed history of Raymond James Financial Inc transactions in Legend Biotech Corp stock. As of the latest transaction made, Raymond James Financial Inc holds 41,744 shares of LEGN stock, worth $1.26 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
41,744
Previous 2,190
1806.12%
Holding current value
$1.26 Million
Previous $77,000
1667.53%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding LEGN
# of Institutions
223Shares Held
57.5MCall Options Held
231KPut Options Held
626K-
Westfield Capital Management CO LP Boston, MA6.09MShares$185 Million0.91% of portfolio
-
Hhlr Advisors, Ltd. Grand Cayman, E95.98MShares$181 Million5.86% of portfolio
-
Black Rock Inc. New York, NY5.72MShares$173 Million0.01% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.82MShares$116 Million3.74% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY2.96MShares$89.7 Million1.8% of portfolio
About Legend Biotech Corp
- Ticker LEGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 167,403,008
- Market Cap $5.07B
- Description
- Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...